aspirin has been researched along with Biliary Tract Cancer in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to examine aspirin use on cancer-specific survival in various BTC subtypes, including gallbladder cancer, ampulla of Vater cancer, and cholangiocarcinoma." | 8.02 | Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort. ( Chan, C; Chen, CJ; Chen, YJ; Hsieh, RJ; Huang, C; Huang, CP; Huang, YH; Jackson, SS; Koshiol, J; Lee, MH; Liao, SF; Liu, PC; Lu, SN; Shen, CY, 2021) |
| "The impact of statins, aspirin and metformin use on recurrence-free (RFS) and overall survival (OS) of patients with biliary tract cancer (BTC) has not been evaluated." | 7.81 | Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer. ( Aneja, P; Horgan, AM; Knox, JJ; Le, LW; McKeever, E; McNamara, MG, 2015) |
| " However, the effect of nonsteroidal anti-inflammatory drugs, such as aspirin, on biliary tract cancer has not been well studied." | 7.73 | Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. ( Deng, J; Fraumeni, JF; Gao, YT; Han, TQ; Hsing, AW; Liu, E; Rashid, A; Sakoda, LC; Shen, MC; Wang, BS; Zhang, BH, 2005) |
| " We aimed to examine aspirin use on cancer-specific survival in various BTC subtypes, including gallbladder cancer, ampulla of Vater cancer, and cholangiocarcinoma." | 4.02 | Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort. ( Chan, C; Chen, CJ; Chen, YJ; Hsieh, RJ; Huang, C; Huang, CP; Huang, YH; Jackson, SS; Koshiol, J; Lee, MH; Liao, SF; Liu, PC; Lu, SN; Shen, CY, 2021) |
| "The impact of statins, aspirin and metformin use on recurrence-free (RFS) and overall survival (OS) of patients with biliary tract cancer (BTC) has not been evaluated." | 3.81 | Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer. ( Aneja, P; Horgan, AM; Knox, JJ; Le, LW; McKeever, E; McNamara, MG, 2015) |
| " However, the effect of nonsteroidal anti-inflammatory drugs, such as aspirin, on biliary tract cancer has not been well studied." | 3.73 | Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. ( Deng, J; Fraumeni, JF; Gao, YT; Han, TQ; Hsing, AW; Liu, E; Rashid, A; Sakoda, LC; Shen, MC; Wang, BS; Zhang, BH, 2005) |
| "Patients with advanced biliary tract cancers (BTCs) have poor prognoses and limited therapeutic options." | 1.91 | Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy. ( Choi, E; Gunchick, V; McDevitt, RL; Sahai, V; Winslow, K; Zalupski, MM, 2023) |
| "Metformin was not associated with BTC risk (HR, 0." | 1.72 | Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study. ( Borad, MJ; Brusselaers, N; Harmsen, WS; Marcano-Bonilla, L; Patel, T; Petersen, GM; Roberts, LR; Sadr-Azodi, O; Schleck, CD; Therneau, TM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 8 (72.73) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, HY | 1 |
| Wang, CC | 1 |
| Wei, JC | 1 |
| Marcano-Bonilla, L | 1 |
| Schleck, CD | 1 |
| Harmsen, WS | 1 |
| Sadr-Azodi, O | 2 |
| Borad, MJ | 1 |
| Patel, T | 1 |
| Petersen, GM | 1 |
| Therneau, TM | 1 |
| Roberts, LR | 1 |
| Brusselaers, N | 2 |
| Gunchick, V | 1 |
| McDevitt, RL | 1 |
| Choi, E | 1 |
| Winslow, K | 1 |
| Zalupski, MM | 1 |
| Sahai, V | 1 |
| Jackson, SS | 3 |
| Pfeiffer, RM | 2 |
| Liu, Z | 1 |
| Anderson, LA | 1 |
| Tsai, HT | 1 |
| Gadalla, SM | 1 |
| Koshiol, J | 3 |
| Bergquist, JR | 1 |
| Shariq, OA | 1 |
| Visser, BC | 1 |
| Liao, SF | 1 |
| Huang, YH | 2 |
| Chan, C | 1 |
| Huang, C | 1 |
| Liu, PC | 1 |
| Chen, YJ | 1 |
| Hsieh, RJ | 1 |
| Huang, CP | 1 |
| Lu, SN | 1 |
| Chen, CJ | 1 |
| Shen, CY | 1 |
| Lee, MH | 1 |
| Kamal, H | 1 |
| Engstrand, L | 1 |
| Zhang, JW | 1 |
| Yang, X | 1 |
| Ding, HR | 1 |
| Zhang, L | 1 |
| Xu, YY | 1 |
| Sang, XT | 1 |
| Zhao, HT | 1 |
| Zhang, WG | 1 |
| Lu, X | 1 |
| McNamara, MG | 1 |
| Aneja, P | 1 |
| Le, LW | 1 |
| Horgan, AM | 1 |
| McKeever, E | 1 |
| Knox, JJ | 1 |
| Liu, E | 1 |
| Sakoda, LC | 1 |
| Gao, YT | 1 |
| Rashid, A | 1 |
| Shen, MC | 1 |
| Wang, BS | 1 |
| Deng, J | 1 |
| Han, TQ | 1 |
| Zhang, BH | 1 |
| Fraumeni, JF | 1 |
| Hsing, AW | 1 |
11 other studies available for aspirin and Biliary Tract Cancer
| Article | Year |
|---|---|
Letter to the Editor: Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biliary Tract Neoplasms; Humans | 2022 |
Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile Ducts, Intra | 2022 |
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Asp | 2023 |
Association Between Aspirin Use and Biliary Tract Cancer Survival.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biliary Tract Neoplasms; Case-Control Studi | 2019 |
Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer.
Topics: Aspirin; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Humans | 2020 |
Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer-Reply.
Topics: Aspirin; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Humans | 2020 |
Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.
Topics: Aged; Aged, 80 and over; Ampulla of Vater; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Du | 2021 |
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile | 2021 |
Letter to the Editor: Is Aspirin a Drug or Just a Marker for Biliary Cancer?
Topics: Arthroplasty, Replacement, Knee; Aspirin; Biliary Tract Neoplasms; Biomarkers; Humans; Pharmaceutica | 2021 |
Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
Topics: Aged; Aspirin; Biliary Tract Neoplasms; Cardiovascular Agents; Comorbidity; Disease Progression; Dis | 2015 |
Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biliary Tract Neoplasms; Case-Control | 2005 |